Prevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy.

Translated title of the contribution: Prevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy.
  • M.C. Minnema
  • , I. Breitkreutz
  • , J.J. Auwerda
  • , B. van der Holt
  • , F.W. Cremer
  • , A.M.W. van Marion
  • , P.H. Westveer
  • , P. Sonneveld
  • , H. Goldschmidt
  • , H.M. Lokhorst

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionPrevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy.
Original languageUndefined/Unknown
Pages (from-to)2044-2046
Number of pages3
JournalLeukemia
Volume18
Issue number12
Publication statusPublished - 2004

Cite this